Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs VENUS REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA VENUS REMEDIES DISHMAN PHARMA/
VENUS REMEDIES
 
P/E (TTM) x 30.0 14.7 204.2% View Chart
P/BV x 3.3 0.6 554.7% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 DISHMAN PHARMA   VENUS REMEDIES
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
VENUS REMEDIES
Mar-22
DISHMAN PHARMA/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs374639 58.6%   
Low Rs129261 49.4%   
Sales per share (Unadj.) Rs197.0447.8 44.0%  
Earnings per share (Unadj.) Rs21.230.5 69.6%  
Cash flow per share (Unadj.) Rs34.755.5 62.5%  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs179.9329.4 54.6%  
Shares outstanding (eoy) m80.7013.37 603.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.0 127.2%   
Avg P/E ratio x11.914.8 80.5%  
P/CF ratio (eoy) x7.38.1 89.6%  
Price / Book Value ratio x1.41.4 102.5%  
Dividend payout %9.40-   
Avg Mkt Cap Rs m20,3076,011 337.8%   
No. of employees `000NANA-   
Total wages/salary Rs m5,355523 1,023.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,8985,987 265.6%  
Other income Rs m26583 319.4%   
Total revenues Rs m16,1636,070 266.3%   
Gross profit Rs m4,103621 660.6%  
Depreciation Rs m1,091335 325.2%   
Interest Rs m9445 19,634.1%   
Profit before tax Rs m2,334364 641.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m624-43 -1,444.9%   
Profit after tax Rs m1,710407 419.9%  
Gross profit margin %25.810.4 248.8%  
Effective tax rate %26.7-11.9 -225.4%   
Net profit margin %10.86.8 158.1%  
BALANCE SHEET DATA
Current assets Rs m11,0182,780 396.3%   
Current liabilities Rs m9,517927 1,026.2%   
Net working cap to sales %9.431.0 30.5%  
Current ratio x1.23.0 38.6%  
Inventory Days Days5721 267.7%  
Debtors Days Days3235 1.5%  
Net fixed assets Rs m18,7873,011 624.0%   
Share capital Rs m161134 120.7%   
"Free" reserves Rs m14,3544,271 336.1%   
Net worth Rs m14,5164,404 329.6%   
Long term debt Rs m4,189387 1,083.1%   
Total assets Rs m29,8055,791 514.7%  
Interest coverage x3.576.7 4.5%   
Debt to equity ratio x0.30.1 328.7%  
Sales to assets ratio x0.51.0 51.6%   
Return on assets %8.97.1 125.2%  
Return on equity %11.89.2 127.4%  
Return on capital %17.57.7 227.6%  
Exports to sales %24.90-   
Imports to sales %3.70-   
Exports (fob) Rs m3,956NA-   
Imports (cif) Rs m594NA-   
Fx inflow Rs m4,9520-   
Fx outflow Rs m6970-   
Net fx Rs m4,2550-   
CASH FLOW
From Operations Rs m2,786410 679.6%  
From Investments Rs m-1,529-166 919.6%  
From Financial Activity Rs m-941-95 992.9%  
Net Cashflow Rs m317144 220.2%  

Share Holding

Indian Promoters % 61.4 41.8 147.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 23.0 1.1 2,031.0%  
FIIs % 12.0 1.1 1,059.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 58.2 66.3%  
Shareholders   52,291 22,015 237.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    PIRAMAL ENTERPRISES    


More on Dishman Pharma vs VENUS REMEDIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs VENUS REMEDIES Share Price Performance

Period Dishman Pharma VENUS REMEDIES S&P BSE HEALTHCARE
1-Day 2.87% -0.35% -0.10%
1-Month -2.45% -4.40% -1.99%
1-Year 96.38% -54.68% -5.62%
3-Year CAGR 50.28% 104.07% 20.96%
5-Year CAGR 41.17% 13.39% 11.47%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the VENUS REMEDIES share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of VENUS REMEDIES the stake stands at 41.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of VENUS REMEDIES.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

VENUS REMEDIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of VENUS REMEDIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.